Loading publications…
The last 5 uploaded publications
Impact of Lesion Length and Vessel Size on Clinical Outcomes After Percutaneous Coronary Intervention With Everolimus- Versus Paclitaxel-Eluting Stents
Bimmer E. Claessen, Pieter C. Smits, Dean J. Kereiakes, Helen Parise, Martin Fahy, Elvin Kedhi, Patrick W. Serruys, Alexandra J. Lansky, Ecaterina Cristea, Krishnankutty Sudhir, Poornima Sood, Charles A. Simonton, Gregg W. Stone (2011). Impact of Lesion Length and Vessel Size on Clinical Outcomes After Percutaneous Coronary Intervention With Everolimus- Versus Paclitaxel-Eluting Stents. КАРДИОЛОГИЯ УЗБЕКИСТАНА, 4(11), pp. 1209-1215, DOI: 10.1016/j.jcin.2011.07.016.
Article146 days agoCoronary Calcification and Long-Term Outcomes According to Drug-Eluting Stent Generation
Paul Guedeney, Bimmer E. Claessen, Roxana Mehran, Gary S. Mintz, Mengdan Liu, Sabato Sorrentino, Gennaro Giustino, Serdar Farhan, Martin B. Leon, Patrick W. Serruys, Pieter C. Smits, Clemens von Birgelen, Ziad A. Ali, Philippe Généreux, Björn Redfors, Mahesh V. Madhavan, Ori Ben‐Yehuda, Gregg W. Stone (2020). Coronary Calcification and Long-Term Outcomes According to Drug-Eluting Stent Generation. КАРДИОЛОГИЯ УЗБЕКИСТАНА, 13(12), pp. 1417-1428, DOI: 10.1016/j.jcin.2020.03.053.
Article146 days agoTwo-Year Clinical, Angiographic, and Intravascular Ultrasound Follow-Up of the XIENCE V Everolimus-Eluting Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions
Bimmer E. Claessen, Marcel A.M. Beijk, Victor Legrand, Witold Rużyłło, Antonio Manari, Olivier Varenne, Maarten J. Suttorp, Jan G.P. Tijssen, Karine Miquel‐Hébert, Susan Veldhof, José P.S. Henriques, Patrick W. Serruys, Jan J. Piek (2009). Two-Year Clinical, Angiographic, and Intravascular Ultrasound Follow-Up of the XIENCE V Everolimus-Eluting Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions. Circulation Cardiovascular Interventions, 2(4), pp. 339-347, DOI: 10.1161/circinterventions.108.831800.108.831800.
Article146 days agoTwo-Year Clinical, Angiographic, and Intravascular Ultrasound Follow-Up of the XIENCE V Everolimus-Eluting Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions: The SPIRIT II Trial
Bimmer E. Claessen, M. A. Beijk, V. Legrand, W. Ruzyllo, A. Manari, O. Varenne, M. J. Suttorp, Jan G.P. Tijssen, Karine Miquel‐Hébert, S. Veldhof, J. P.S. Henriques, Patrick W. Serruys, J. J. Piek (2009). Two-Year Clinical, Angiographic, and Intravascular Ultrasound Follow-Up of the XIENCE V Everolimus-Eluting Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions: The SPIRIT II Trial. Circulation Cardiovascular Interventions, 2(4), pp. 339-347, DOI: 10.1161/circinterventions.108.831800.
Article146 days agoOutcomes of Vascular Closure Device Use After Transfemoral Coronary Intervention: Insights From the EXCEL Trial
Toshiki Kuno, Bimmer E. Claessen, Paul Guedeney, Patrick W. Serruys, Joseph F. Sabik, Charles A. Simonton, David E. Kandzari, Marie‐Claude Morice, Zixuan Zhang, Ovidiu Dressler, Roxana Mehran, Ori Ben‐Yehuda, A. Pieter Kappetein, Gregg W. Stone (2021). Outcomes of Vascular Closure Device Use After Transfemoral Coronary Intervention: Insights From the EXCEL Trial. Deleted Journal, 33(8), DOI: 10.25270/jic/20.00715.
Article146 days ago